eMC Medicine Guides  
The electronic Medicines Compendium (eMC) contains information about UK licensed medicines.
go to eMC homepage
Search for:  
  Advanced Search

Merck Sharp & Dohme Limited
Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU
Telephone: +44 (0)1992 467 272
Fax: +44 (0)1992 479 292
Medical Information e-mail: medicalinformationuk@merck.com

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 23/08/2011
PIL Singulair Paediatric 4 mg tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 23/08/2011 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
Updated on 05/07/2010 and displayed until 23/08/2011
Reasons for adding or updating:
  • Change to side-effects
Updated on 07/09/2009 and displayed until 05/07/2010
Reasons for adding or updating:
  • Change to side-effects
Updated on 23/03/2009 and displayed until 07/09/2009
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to side-effects
Updated on 11/08/2008 and displayed until 23/03/2009
Reasons for adding or updating:
  • Change to side-effects
Updated on 04/06/2008 and displayed until 11/08/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 07/12/2007 and displayed until 04/06/2008
Reasons for adding or updating:
  • Change due to harmonisation of patient information leaflet
  • Change due to user-testing of patient information
  • Change to side-effects
  • Addition of separate PILs covering individual presentations
Updated on 07/07/2006 and displayed until 07/12/2007
Reasons for adding or updating:
  • Change to drug interactions
Updated on 02/05/2006 and displayed until 07/07/2006
Reasons for adding or updating:
  • Change to, or new, use for medicine
Updated on 27/01/2006 and displayed until 02/05/2006
Reasons for adding or updating:
  • Change to side-effects
  • Change to drug interactions
Updated on 20/01/2004 and displayed until 27/01/2006
Reasons for adding or updating:
  • Update to PIL
Updated on 18/02/2003 and displayed until 20/01/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 21/12/2001 and displayed until 18/02/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 30/07/2001 and displayed until 21/12/2001
Reasons for adding or updating:
  • Update to PIL
Updated on 06/02/2001 and displayed until 30/07/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
  montelukast sodium